Ledger.Open graph →
SEC Form D · filed May 24, 2023

Auxergen Biolongevity Laboratory

Offering
$5.0M
Sold
$25K
Exemption
Rule 506(b)
Industry
Other
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Gregory P. Contreras · Baltimore, MDExec · DirectorTing Yu Yeh · Baltimore, MDExec · DirectorGregory P. Contreras · Baltimore, MDExec · DirectorTing Yu Yeh · Baltimore, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗